Cutaneous presentations of omphalomesenteric duct remnant: A systematic review of the literature - 11/10/19
, Moshe Lapidoth, MD, MPH a, b, Igor Snast, MD a, b, Dan Ben-Amitai, MD b, c, Omri Zidan, MD a, b, Rivka Friedland, MD b, c, Michael Moshe, MD b, d, Daniel Mimouni, MD a, b, Yael Ann Leshem, MD, MCR a, b, Emmilia Hodak, MD a, b, Assi Levi, MD a, bAbstract |
Background |
Disorders of the umbilicus are commonly seen in infancy, including hernias, infections, anomalies, granulomas, and malignancies. Meticulous inspection of the umbilicus at birth might reveal a persisting embryonic remnant, such as an omphalomesenteric duct (OMD), manifested by a variety of cutaneous signs, such as an umbilical mass, granulation tissue, or discharge.
Objective |
To systematically review the available data regarding the presence and management of OMD remnant with cutaneous involvement to suggest a practical approach for diagnosis and treatment.
Methods |
A systematic review of the literature evaluating OMD anomalies presenting with cutaneous symptoms was performed. In addition, an index case of an 11-month-old patient is presented.
Results |
We included 59 publications reporting 536 cases; 97% of the patients whose age was noted were infants (mean age 11 months). In 7.5% of the cases, diagnosis was established only after treatment failure. In 6.4% of patients, nonlethal complications were reported, and in 10.3%, the outcome was death, partly due to delayed diagnosis or mismanagement.
Limitations |
Limited quality of the collected data, reporting bias.
Conclusion |
OMD is relatively rare; however, the clinician must consider this remnant while examining patients with umbilical abnormalities because mismanagement could cause severe morbidity and mortality.
Le texte complet de cet article est disponible en PDF.Key words : Meckel's diverticulum, omphalomesenteric duct, pyogenic granuloma, umbilical anomalies, umbilical polyp, umbilicoileal fistula, vitelline duct
Abbreviation used : MeSH, OMD
Plan
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the author. |
Vol 81 - N° 5
P. 1120-1126 - novembre 2019 Retour au numéro
Article précédent
- Optimizing the total-body skin exam: An observational cohort study
- Matthew F. Helm, Katherine K. Hallock, Elizabeth Bisbee, Jeffrey J. Miller
- Expression of programmed cell death ligand 1 and programmed cell death 1 in cutaneous warts
- Wesley Y. Yu, Timothy G. Berger, Jeffrey P. North, Zoltan Laszik, Jarish N. Cohen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?